Biotechnology
Healthcare
Medical

GlaxoSmithKline

$40.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.19 (0.48%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell GSK and other stocks, options, ETFs, and crypto commission-free!

About

GlaxoSmithKline plc, also called GlaxoSmithKline, is a global healthcare company which engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products. It operates through the following four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. Read More The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Employees
95,490
Headquarters
Brentford, Greater London
Founded
1999
Market Cap
99.37B
Price-Earnings Ratio
19.42
Dividend Yield
5.40
Average Volume
2.79M
High Today
$40.32
Low Today
$40.08
Open Price
$40.16
Volume
494.49K
52 Week High
$42.36
52 Week Low
$36.41

Collections

Biotechnology
Healthcare
Medical
Pharmaceutical
Female CEOs
Health
Research And Development
Health And Wellness

News

ReutersMay 24

UK Stocks-Factors to watch on May 24

May 24 (Reuters) - Britain's FTSE 100 index is seen opening 14 points higher at 7,245 on Friday, according to financial bookmakers.

54
Yahoo FinanceMay 23

GSK to change incentives for sales representatives

(Reuters) - British drugmaker GlaxoSmithKline said on Thursday it will change incentives for sales representatives in some countries as it looks to retain talent.

40
Seeking AlphaMay 22

Glaxo's Shingrix conditionally OK'd in China

FiercePharma reports that China's National Medical Products Administration has conditionally approved GlaxoSmithKline's (GSK +1.1% ) shingles vaccine Shingrix, allowing it to file for approval there based on data generated in other countries.

26

Earnings

$0.34
$0.52
$0.70
$0.88
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Jul 24

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.